Association of glomerulopathy with the 5′-end polymorphism of the aldose reductase gene and renal insufficiency in type 2 diabetic patients

Diabetes

Volumn 53, Issue 11, 2004, Pages 2984-2991

  Zhao, Hai Lu ^a   Tong, Peter C Y ^a   Lai, Fernand M M ^a   Tomlinson, Brian ^a   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALPHA ACTIN; COLLAGEN TYPE 4; CREATININE; FIBRONECTIN; GROWTH FACTOR; LAMININ; TRANSFORMING GROWTH FACTOR BETA1;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; ATYPICAL DIABETIC GLOMERULOPATHY; AUTOPSY; CELL DIFFERENTIATION; CLASSIC DIABETIC GLOMERULOPATHY; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DNA POLYMORPHISM; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE MUTATION; GLOMERULUS; GLOMERULUS FILTRATION; HETEROZYGOTE; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY STRUCTURE; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

5' UNTRANSLATED REGIONS; ALDEHYDE REDUCTASE; AUTOPSY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY GLOMERULUS;

EID: 7044249529     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.11.2984     Document Type: Article

References (52)

1. Ritz E, Rychlik I, Locatelli F, Halimi S: End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795-808, 1999
2. Chan JC, Cockram CS: Diabetes in the Chinese population and its implications for health care. Diabetes Care 20:1785-1790, 1997
3. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414:782-787, 2001
4. Koch M, Kutkuhn B, Grabensee B, Ritz E: Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant 12:2603-2611, 1997
5. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
6. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus: Diabetic Renal Disease Study Group. N Engl J Med 335:1636-1642, 1996
7. Brocco E, Fioretto P, Mauer M, Saller A, Carraro A, Frigato F, Chiesura-Corona M, Bianchi L, Baggio B, Maioli M, Abaterusso C, Velussi M, Sambataro M, Virgili F, Ossi E, Nosadini R: Renal structure and function in non-insulin-dependent diabetic patients with microalbuminuria. Kidney Int 52 (Suppl. 63):S40-S44, 1997
8. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R: Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39:1569-1576, 1996
9. Gambara V, Mecca G, Remuzzi G, Bertani T: Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol 3:1458-1466, 1993
10. Mazzucco G, Bertani T, Fortunato M, Bernardi M, Leutner M, Boldorini R, Monga G: Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 39:713-720, 2002
11. White KE, Bilous RW: Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol 11:1667-1673, 2000
12. Ritz E, Orth SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127-1133, 1999
13. Lindner TH, Monks D, Wanner C, Berger M: Genetic aspects of diabetic nephropathy. Kidney Int 63 (Suppl. 84):S186-S191, 2003
14. Parving HH, Tarnow L, Rossing P: Genetics of diabetic nephropathy. J Am Soc Nephrol 7:2509-2517, 1996
15. Ziyadeh FN, Han DC: Involvement of transforming growth factor-beta and its receptors in the pathogenesis of diabetic nephrology. Kidney Int 51 (Suppl. 60):S7-S11, 1997
16. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-de la Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 97:8015-8020, 2000
17. Ziyadeh FN: Mediators of diabetic renal disease: the case for TGF-beta as the major mediator. J Am Soc Nephrol 15 (Suppl. 1):S55-S57, 2004
18. Chen S, Jim B, Ziyadeh FN: Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23:532-543, 2003
19. Gambaro G, D'Angelo A, Del Prete D, Ceol M, Garbisa S, Bertaglia G, Forino M, Baggio B, Anglani F: Mesangial cell proliferation in long-term streptozotocin-induced diabetes mellitus in the rat and the renoprotective activity of heparin. Am J Nephrol 19:530-534, 1999
20. Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Okamoto K, Maeshima Y, Ota Z, Nagai R: Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes 45:488-495, 1996
21. Sanai T, Sobka T, Johnson T, el-Essawy M, Muchaneta-Kubara EC, Ben Gharbia O, el Oldroyd S, Nahas AM: Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy. Diabetologia 43:91-100, 2000
22. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146, 1995
23. Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE: Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14:968-980, 2003
24. Hellmich B, Schellner M, Schatz H, Pfeiffer A: Activation of transforming growth factor-beta1 in diabetic kidney disease. Metabolism 49:353-359, 2000
25. Nerlich AG, Schleicher ED, Wiest I, Specks U, Timpl R: Immunohistochemical localization of collagen VI in diabetic glomeruli. Kidney Int 45:1648-1656, 1994
26. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 90:1814-1818, 1993
27. Liu YF, Wat NM, Chung SS, Ko BC, Lam KS: Diabetic nephropathy is associated with the 5′-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with type 2 diabetes. Diabet Med 19:113-118, 2002
28. Shah VO, Scavini M, Nikolic J, Sun Y, Vai S, Griffith JK, Dorin RI, Stidley C, Yacoub M, Vander Jagt DL, Eaton RP, Zager PG: Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab 83:2886-2891, 1998
29. Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS, Critchley JA, Chan JC: Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care 26:2410-2415, 2003
30. Maeda S, Haneda M, Yasuda H, Tachikawa T, Isshiki K, Koya D, Terada M, Hidaka H, Kashiwagi A, Kikkawa R: Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes. Diabetes 48:420-422, 1999
31. Moczulski DK, Burak W, Doria A, Zychma M, Zukowska-Szczechowska E, Warram JH, Grzeszczak W: The role of aldose reductase gene in the susceptibility to diabetic nephropathy in type II (non-insulin-dependent) diabetes mellitus. Diabetologia 42:94-97, 1999
32. Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich SS, Warram JH, Krolewski AS: Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in type 1 diabetes mellitus. Diabet Med 17:111-118, 2000
33. Neamat-Allah M, Feeney SA, Savage DA, Maxwell AP, Hanson RL, Knowler WC, El Nahas AM, Plater ME, Shaw J, Boulton AJ, Duff GW, Cox A: Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in type 1 and type 2 diabetes mellitus. Diabet Med 18:906-914, 2001
34. Park HK, Ahn CW, Lee GT, Kim SJ, Song YD, Lim SK, Kim KR, Huh KB, Lee HC: (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus. Diabetes Res Clin Pract 55:151-157, 2002
35. Zhao HL, Lai FM, Tong PC, Zhong DR, Yang D, Tomlinson B, Chan JC: Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes 52:2759-2766, 2003
36. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
37. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
38. Puchtler H, Sweat F, Levine M: On the binding of Congo red by amyloid. J Histochem Cytochem 10:355-364, 1962
39. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, Liu D, Lim H, Taylor CR: DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem 50:1005-1011, 2002
40. Booth E, Montgomery PO, Muirhead EE: The glomerular lesions of diabetes mellitus, cellular hyaline and acellular hyaline lesions of intercapillary glomerulosclerosis as depicted by histochemical studies. Arch Intern Med 98:146-161, 1956
41. Jones CL, Eddy AA: Tubulointerstitial nephritis. Pediatr Nephrol 6:572-586, 1992
42. Nerlich A, Schleicher E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889-899, 1991
43. Schmitz A, Vaeth M: Microalbuminuria: a major risk factor in non-insulin-dependent diabetes: a 10-year follow-up study of 503 patients. Diabet Med 5:126-134, 1988
44. Ruggenenti P, Gambara V, Perna A, Bertani T, Remuzzi G: The nephropathy of non-insulin-dependent diabetes: predictors of outcome relative to diverse patterns of renal injury. J Am Soc Nephrol 9:2336-2343, 1998
45. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
46. Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med 39:465-490, 1988
47. Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28:830-838, 1985
48. Nielsen S, Rehling M, Schmitz A, Mogensen CE: Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function. Nephrol Dial Transplant 14:615-619, 1999
49. Fioretto P, Steffes MW, Mauer M: Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43:1358-1364, 1994
50. Zou X-M, Zhao H-L, Song H-J, Lu J-M, Pan C-Y: Association of the Z-2 and Z+2 allele of aldose reductase gene with its erythrocyte activity and diabetic microangiopathy in Chinese with type 2 diabetes (Abstract). Diabetes Res Clin Pract 57 (Suppl. 1):S27-S28, 2002
51. Ishii H, Tada H, Isogai S: An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells. Diabetalogia 41:362-364, 1998
52. Phillips A, Steadman R, Morrisey K, Martin J, Eynstone L, Williams J: Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation. Kidney Int 52:973-984, 1997